FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

30297311000001103: Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94045901000001118 Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94046001000001110 Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule Has VMP Tetracosactrin 250micrograms/1mL injection false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule Has specific active ingredient Tetracosactide acetate true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule Has VMP Tetracosactide 250micrograms/1ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule Has VMP Tetracosactide 250micrograms/1ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) 1 ampoule Is a True Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start